Heparin-induced Thrombocytopenia During Multiple Extracorporeal Mechanical Support for Fulminant Myocarditis: A Case Report with a Literature Review
Case report published in Internal Medicine (2026)
Abstract
Heparin-induced thrombocytopenia (HIT) is a potentially fatal complication of heparin therapy, particularly during extracorporeal mechanical support requiring anticoagulation. We report the case of a 57-year-old woman with fulminant myocarditis complicated by acute kidney injury who was transferred while receiving extracorporeal membrane oxygenation and continuous renal replacement therapy with unfractionated heparin. After transfer, a rapid platelet decline and repeated circuit occlusions raised a strong suspicion of HIT based on the 4Ts score. Heparin was replaced with nafamostat mesilate or argatroban, and HIT antibodies were detected. Both bleeding and thrombotic complications occurred during intensive care, thus reflecting the complexity of managing critically ill patients receiving multiple extracorporeal mechanical supports.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Fulminant myocarditis on ECMO and CRRT complicated by HIT with rapid platelet decline and repeated circuit occlusion; heparin replaced with nafamostat mesilate or argatroban, illustrating the complexity of HIT management during multi-modal extracorporeal support.
Por qué esto importa para la hirudoterapia
Este reporte de caso describe a una mujer de 57 años en ECMO y terapia continua de reemplazo renal que desarrolló sospecha de trombocitopenia inducida por heparina (TIH), lo que requirió la transición de heparina no fraccionada a mesilato de nafamostat o argatrobán, confirmándose posteriormente los anticuerpos anti-TIH. El reporte es indirectamente relevante para el ámbito de ASH en la medida en que ilustra el desafío clínico de la anticoagulación en el soporte extracorpóreo cuando la heparina fracasa, un escenario en el que la inhibición directa de la trombina (el mecanismo de la hirudina derivada de la sanguijuela) resulta conceptualmente pertinente. ADVERTENCIA: Este artículo no involucra sanguijuelas, hirudoterapia ni bivalirudina; los agentes alternativos empleados (nafamostat, argatrobán) no se derivan de sanguijuelas, por lo que la relevancia para la hirudoterapia es completamente indirecta y conceptual.
Citación
Heparin-induced Thrombocytopenia During Multiple Extracorporeal Mechanical Support for Fulminant Myocarditis: A Case Report with a Literature Review.
Morita Y et al. · Internal Medicine (Tokyo), 2026
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026